The 5-HT3 receptor antagolist ALOXI® launched in Japan

22 April 2010

Galen Partners Invests in Nautilus Neurosciences, Inc. Funding to Provide Growth Capital for the Launch of CAMBIA™

13 April 2010

Cerbios appoints Stefano Console as Director Commercial Business Development

2 April 2010

APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the European Approval of Ondansetron RapidFilm™

23 March 2010

Oncology: Palonosetron approved in Japan, second pharmaceutical market worldwide

20 January 2010